Clinical Trial Update: Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Adebrelimab with chemotherapy, endoscopy, and sequential chemoradiotherapy in esophageal squamous cell carcinoma; status shows…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Resectable Esophageal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING